BVAXF
Price:
$0.0498
Market Cap:
$17.82M
BioVaxys Technology Corp., a clinical biotechnology company, develops antiviral and anticancer vaccine platforms. It develops BVX-0320, a monovalent SARS-CoV-2 vaccine; and BVX-0918A, a haptenized tumor cell vaccine for ovarian cancer, as well as CoviDTH, which screens for an immune system response in patients exposed to SARS-CoV-2. The company is also developing Papilocare for human papilloma virus (HPV)-dependent cervical lesions; BVX-0918C for cervical cancer; BVX-0204 HPV viral vaccine; and BVX-0121, a multivalent SARS-CoV-2 vaccine. BioVaxys Technology Corp. has a bioproduction agreement with WuXi Biologics Limited that produces SARS-CoV-2 s-proteins for BVX-0320 and CoviDTH; research c...[Read more]
Industry
Biotechnology
IPO Date
2018-12-28
Stock Exchange
PNK
Ticker
BVAXF
According to BioVaxys Technology Corp.’s latest financial reports and current stock price. The company's current Enterprise Value is 17.41M. This represents a change of 82.76% compared to the average of 9.53M of the last 4 quarters.
The mean historical Enterprise Value of BioVaxys Technology Corp. over the last ten years is 10.51M. The current 17.41M Enterprise Value has changed 16.46% with respect to the historical average. Over the past ten years (40 quarters), BVAXF's Enterprise Value was at its highest in in the October 2021 quarter at 33.36M. The Enterprise Value was at its lowest in in the October 2018 quarter at 0.
Average
10.51M
Median
6.05M
Minimum
-15649.00
Maximum
30.18M
Discovering the peaks and valleys of BioVaxys Technology Corp. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.58%
Maximum Annual Enterprise Value = 30.18M
Minimum Annual Increase = -3947.96%
Minimum Annual Enterprise Value = -15649.00
Year | Enterprise Value | Change |
---|---|---|
2023 | 2.01M | -90.07% |
2022 | 20.23M | -32.96% |
2021 | 30.18M | 199.16% |
2020 | 10.09M | 1.58% |
2019 | 602.17K | -3947.96% |
The current Enterprise Value of BioVaxys Technology Corp. (BVAXF) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
17.47M
5-year avg
12.62M
10-year avg
10.51M
BioVaxys Technology Corp.’s Enterprise Value is greater than Biotron Limited (16.98M), greater than Bioasis Technologies Inc. (397.14K), less than Covalon Technologies Ltd. (93.17M), greater than Mosaic ImmunoEngineering Inc. (8.29M), greater than Ceapro Inc. (16.01M), less than Cellectis S.A. (115.55M), greater than Adial Pharmaceuticals, Inc. WT EXP 073123 (1.27M), less than Small Pharma Inc. (0), less than TRACON Pharmaceuticals, Inc. (34.51M), greater than Wesana Health Holdings Inc. (-6162490.00), greater than GH Research PLC (255.22K), less than Algernon Pharmaceuticals Inc. (392.97M), greater than AXIM Biotechnologies, Inc. (1.14M), greater than null (7.10M),
Company | Enterprise Value | Market cap |
---|---|---|
16.98M | $11.30M | |
397.14K | $284.08K | |
93.17M | $72.60M | |
8.29M | $7.24M | |
16.01M | $13.31M | |
115.55M | $183.12M | |
1.27M | $0 | |
0 | $37.51M | |
34.51M | $107.51K | |
-6162490.00 | $68.30K | |
255.22K | $482.30M | |
392.97M | $1.25M | |
1.14M | $694.51K | |
7.10M | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioVaxys Technology Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like BioVaxys Technology Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is BioVaxys Technology Corp.'s Enterprise Value?
What is the highest Enterprise Value for BioVaxys Technology Corp. (BVAXF)?
What is the 3-year average Enterprise Value for BioVaxys Technology Corp. (BVAXF)?
What is the 5-year average Enterprise Value for BioVaxys Technology Corp. (BVAXF)?
How does the current Enterprise Value for BioVaxys Technology Corp. (BVAXF) compare to its historical average?